Close Menu
SUBSCRIBE

Jardiance

Jardiance (Empagliflozin): Uses, Dosage, and Side Effects

What is Jardiance?

Jardiance is the brand name for empagliflozin, an oral medication used to improve blood sugar control in adults with type 2 diabetes. It belongs to the drug class known as SGLT2 inhibitors (sodium-glucose co-transporter 2 inhibitors). By reducing glucose reabsorption in the kidneys, Jardiance helps lower blood sugar levels and may also reduce the risk of cardiovascular death in certain patients with heart disease.
A box of Boehringer Ingelheim Jardiance (Empagliflozin) 25 mg film-coated tablets for oral use, containing 100 tablets.
Jardiance (Empagliflozin) 25 mg tablets are used to treat type 2 diabetes and reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease.

Common uses:

  • Type 2 diabetes management (alongside diet and exercise)
  • Reducing the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease
Note: Jardiance is not indicated for type 1 diabetes or diabetic ketoacidosis.

🔗 Learn more: See the full drug profile of Empagliflozin for detailed dosage guidelines, side effects, interactions, and clinical data.

Dr. Andrew Parker is a board-certified internal medicine physician with over 10 years of clinical experience. He earned his medical degree from the University of California, San Francisco (UCSF), and has worked at leading hospitals including St. Mary’s Medical Center. Dr. Parker specializes in patient education and digital health communication. He now focuses on creating clear, accessible, and evidence-based medical content for the public.

Related Posts